Recent News

• 11.08.2025 - NOVEMBER 2025 I MAZE THERAPEUTICS
• 11.06.2025 - NOVEMBER 2025 I MAZE THERAPEUTICS
• 11.06.2025 - NOVEMBER 2025 I MAZE THERAPEUTICS
• 11.06.2025 - NOVEMBER 2025 I MAZE THERAPEUTICS
• 10.14.2025 - October 2025 I MAZE THERAPEUTICS
• 10.06.2025 - Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors
• 10.06.2025 - Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors

Recent Filings

• 11.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.06.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 11.06.2025 - 8-K Current report
• 11.06.2025 - EX-99.1 EX-99.1
• 11.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.17.2025 - S-1 General form for registration of securities under the Securities Act of 1933
• 10.07.2025 - 3 Initial statement of beneficial ownership of securities
• 10.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.06.2025 - 8-K Current report